Lori M. Henderson is CLO & Secretary at Moderna, Inc. (MRNA). They have made 30 open-market trades across 2 companies since 2016, most recently 2021-05-27.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 30 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRNA | SELL | 2021-05-27 | 2021-05-28 | $174.20 | $1.1M | +17.9% | +21.1% | +117.5% |
| MRNA | SELL | 2021-05-25 | 2021-05-27 | $166.58 | $1.1M | +21.7% | +24.8% | +122.7% |
| MRNA | SELL | 2021-05-20 | 2021-05-21 | $159.92 | $1.1M | +19.9% | +27.8% | +130.6% |
| MRNA | SELL | 2021-05-18 | 2021-05-20 | $160.16 | $1.1M | +13.4% | +23.3% | +136.1% |
| MRNA | SELL | 2021-05-13 | 2021-05-14 | $152.60 | $1.0M | +10.4% | +30.4% | +146.2% |
| MRNA | SELL | 2021-05-11 | 2021-05-13 | $151.31 | $999K | +12.2% | +37.5% | +155.4% |
| MRNA | SELL | 2021-05-06 | 2021-05-07 | $147.82 | $976K | -3.7% | +33.9% | +153.8% |
| MRNA | SELL | 2021-05-04 | 2021-05-06 | $185.25 | $1.2M | -3.8% | +32.4% | +152.8% |
| MRNA | SELL | 2021-04-29 | 2021-04-30 | $182.49 | $1.2M | -17.0% | +0.4% | +87.9% |
| MRNA | SELL | 2021-04-27 | 2021-04-29 | $178.29 | $1.2M | -9.5% | +5.2% | +98.9% |
| MRNA | SELL | 2021-04-22 | 2021-04-23 | $168.26 | $1.1M | -5.2% | -4.4% | +88.3% |
| MRNA | SELL | 2021-04-20 | 2021-04-22 | $160.32 | $1.1M | +1.9% | -3.6% | +88.6% |
| MRNA | SELL | 2021-04-15 | 2021-04-16 | $158.76 | $2.1M | +7.2% | -3.7% | +55.9% |
| MRNA | SELL | 2021-04-13 | 2021-04-14 | $146.62 | $968K | +11.7% | +1.5% | +47.9% |
| MRNA | SELL | 2021-04-08 | 2021-04-09 | $132.85 | $877K | +19.1% | +11.4% | +63.5% |
| MRNA | SELL | 2021-04-06 | 2021-04-08 | $130.01 | $1.7M | +17.4% | +18.8% | +66.2% |
| MRNA | SELL | 2021-04-01 | 2021-04-02 | $132.51 | $1.7M | +20.7% | +40.3% | +77.3% |
| MRNA | SELL | 2021-03-30 | 2021-04-01 | $123.30 | $814K | +20.7% | +40.3% | +77.2% |
| MRNA | SELL | 2021-03-25 | 2021-03-26 | $126.88 | $837K | +2.9% | +36.5% | +69.2% |
| MRNA | SELL | 2021-03-23 | 2021-03-25 | $145.55 | $1.9M | -1.4% | +33.2% | +59.0% |
| MRNA | SELL | 2021-03-18 | 2021-03-19 | $144.39 | $1.9M | -9.2% | +12.3% | +40.4% |
| MRNA | SELL | 2021-03-16 | 2021-03-18 | $148.50 | $980K | -17.2% | +13.2% | +38.3% |
| MRNA | SELL | 2021-03-11 | 2021-03-12 | $133.29 | $880K | -3.8% | +1.9% | +58.7% |
| MRNA | SELL | 2021-03-09 | 2021-03-10 | $127.11 | $839K | +9.5% | +6.0% | +60.2% |
| MRNA | SELL | 2021-03-04 | 2021-03-05 | $128.58 | $1.7M | +14.2% | +0.6% | +51.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.